In fact, the function of IL-17 may also change according to the disease phase in pancreatic cancer: tumor growth is supported by IL-17 in the initial phases, while in the advanced phases, IL-17 promotes anti-tumor immunity [44]. This evidence concerns the gene IL17A and familial pancreatic carcinoma.